Wealth Enhancement Advisory Services Portfolio holdings
AUM
$60.4B
1-Year Return
15.61%
This Quarter Return
+8.75%
1 Year Return
+15.61%
3 Year Return
+48.2%
5 Year Return
+69.03%
10 Year Return
+118.46%
AUM
$60.4B
AUM Growth
+$8.15B
(+16%)
Cap. Flow
+$3.79B
Cap. Flow
% of AUM
6.27%
Top 10 Holdings %
Top 10 Hldgs %
23.67%
Holding
3,471
New
502
Increased
1,628
Reduced
1,086
Closed
148
Top Buys
| 1 |
JMTG
JPMorgan Mortgage-Backed Securities ETF
JMTG
|
$141M |
| 2 |
iShares Core US Aggregate Bond ETF
AGG
|
$129M |
| 3 |
iShares Core S&P Small-Cap ETF
IJR
|
$128M |
| 4 |
ALPS Smith Core Plus Bond ETF
SMTH
|
$126M |
| 5 |
Microsoft
MSFT
|
$113M |
Top Sells
| 1 |
Palantir
PLTR
|
$150M |
| 2 |
JPMorgan Short Duration Core Plus ETF
JSCP
|
$78.1M |
| 3 |
Berkshire Hathaway Class B
BRK.B
|
$59.3M |
| 4 |
CBRE Group
CBRE
|
$36.7M |
| 5 |
UnitedHealth
UNH
|
$28.9M |
Sector Composition
| 1 | Technology | 12.76% |
| 2 | Financials | 6.58% |
| 3 | Industrials | 4.51% |
| 4 | Consumer Discretionary | 3.84% |
| 5 | Healthcare | 3.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
URG
3251
Ur-Energy
URG
$565M
| $22.9K | ﹤0.01% |
+21,039
| New | +$22.9K |
|
3252
Altice USA
ATUS
$1.09B
| $22.5K | ﹤0.01% |
+10,144
| New | +$22.5K |
|
3253
Allogene Therapeutics
ALLO
$246M
| $22.3K | ﹤0.01% |
18,736
-524
| -3% | -$624 |
|
3254
Destination XL Group
DXLG
$71.7M
| $22.2K | ﹤0.01% |
18,480
+20
| +0.1% | +$24 |
|
3255
DocGo
DCGO
$148M
| $22.1K | ﹤0.01% |
+13,969
| New | +$22.1K |
|
|
CAN
3256
Canaan Creative
CAN
$335M
| $21.1K | ﹤0.01% |
+30,000
| New | +$21.1K |
|
3257
GrafTech
EAF
$239M
| $20.6K | ﹤0.01% |
1,985
-462
| -19% | -$4.81K |
|
3258
DarioHealth
DRIO
$24.5M
| $19.9K | ﹤0.01% |
+1,413
| New | +$19.9K |
|
3259
Getty Images
GETY
$747M
| $19.5K | ﹤0.01% |
+10,781
| New | +$19.5K |
|
3260
Incannex Healthcare
IXHL
$54.3M
| $19.2K | ﹤0.01% |
+91,467
| New | +$19.2K |
|
3261
BARK
BARK
$151M
| $18.8K | ﹤0.01% |
+20,595
| New | +$18.8K |
|
3262
Esperion Therapeutics
ESPR
$510M
| $18.2K | ﹤0.01% |
+15,522
| New | +$18.2K |
|
3263
ALX Oncology
ALXO
$57.8M
| $18.1K | ﹤0.01% |
39,279
-1,272
| -3% | -$585 |
|
3264
Gores Guggenheim
PSNY
$2.2B
| $18K | ﹤0.01% |
16,075
+1,960
| +14% | +$2.2K |
|
3265
SKYX Platforms
SKYX
$128M
| $17.9K | ﹤0.01% |
15,946
-15,946
| -50% | -$17.9K |
|
3266
Ocugen
OCGN
$322M
| $16.3K | ﹤0.01% |
17,083
+2,246
| +15% | +$2.15K |
|
3267
Sutro Biopharma
STRO
$86.5M
| $16.2K | ﹤0.01% |
21,201
+4,002
| +23% | +$3.05K |
|
3268
Falcon's Beyond Global, Inc. Warrants
FBYDW
$7M
| $16K | ﹤0.01% |
31,956
| – | – |
|
3269
Accuray
ARAY
$170M
| $15.7K | ﹤0.01% |
+11,058
| New | +$15.7K |
|
3270
Vista Gold
VGZ
$168M
| $14.9K | ﹤0.01% |
14,925
-5,475
| -27% | -$5.46K |
|
3271
Algoma Steel Group Warrant
ASTLW
$5.34M
| $14.6K | ﹤0.01% |
30,000
| – | – |
|
3272
Invivyd
IVVD
$209M
| $12K | ﹤0.01% |
+16,321
| New | +$12K |
|
3273
FiscalNote
NOTE
$57.5M
| $11K | ﹤0.01% |
+1,225
| New | +$11K |
|
3274
Opendoor
OPEN
$4.39B
| $10.9K | ﹤0.01% |
17,927
-59,528
| -77% | -$36.3K |
|
3275
Veru
VERU
$48.3M
| $9.61K | ﹤0.01% |
+1,585
| New | +$9.61K |
|